SecurityPPHM / Peregrine Pharmaceuticals, Inc. (713661304)
Institutional Owners56 (6 N-Q Owners)
Institutional Shares13,709,512 - 24.68% (ex. N-Q)
Common Shares Outstanding55,552,233 shares (as of 2018-01-31)
Institutional Value$ 19,495,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) has 56 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13,709,512 shares. Largest shareholders include Tappan Street Partners LLC, Stafford John S Iii, Vanguard Group Inc, BlackRock Inc., Bandera Partners LLC, Renaissance Technologies LLC, Geode Capital Management, Llc, Wells Fargo & Company/mn, Stifel Financial Corp, and Quinn Opportunity Partners LLC.

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-12 13F-HR Brown Advisory Securities, LLC 82,858 38,299 -53.78 260 149 -42.69
2018-02-14 SC 13G/A Tappan Street Partners LLC 3,915,611 4,516,107 15.34
2018-02-14 13F-HR WOLVERINE TRADING, LLC Call 26,000 0 -100.00 82 0 -100.00
2018-02-09 13F-HR Virtu Financial LLC 19,633 76
2018-02-01 13F-HR Baxter Brothers Inc 21,501 12,215 -43.19 68 47 -30.88
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 4,948 4,490 -9.26 16 17 6.25
2017-11-14 13F-HR PANAGORA ASSET MANAGEMENT INC 5,637 0 -100.00 3 0
2018-02-14 13F-HR/A-1 Taylor Hoffman Wealth Management 72 0
2018-03-09 13F-HR Marino, Stram & Associates Llc 639 2
2018-03-01 N-Q Aqr Funds (see advisory)
2017-11-14 13F-HR Squarepoint Ops LLC 146,100 0 -100.00 89 0 -100.00
2018-01-24 13F-HR IFP Advisors, Inc 3,574 3,043 -14.86 11 12 9.09
2018-02-14 13F-HR MORGAN STANLEY 29,257 49,255 68.35 92 191 107.61
2017-11-14 13F-HR QS Investors, LLC 503,400 0 -100.00 306 0 -100.00
2017-11-14 13F-HR LPL Financial LLC 10,888 0 -100.00 7 0 -100.00
2018-02-09 13F-HR Connor, Clark & Lunn Investment Management Ltd. 98,772 0 -100.00 310 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 32,998 0 -100.00 104 0 -100.00
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 117,829 195,904 66.26 370 760 105.41
2018-02-14 13F-HR A.R.T. Advisors, LLC 44,766 0 -100.00 140 0 -100.00
2017-11-06 13F-HR Sigma Planning Corp 35,000 0 -100.00 21 0 -100.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 0 23 0 3
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 0 37,404 0 145
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 12,038 10,702 -11.10 38 42 10.53
2018-02-13 13F-HR Quinn Opportunity Partners LLC 62,100 92,000 48.15 195 357 83.08
2018-01-31 13F-HR Resources Investment Advisors, Inc. 1,401 0 -100.00 4 0 -100.00
2018-04-06 13F-HR Eqis Capital Management, Inc. 148,176 0 -100.00 575 0 -100.00
2017-11-22 N-Q Legg Mason Global Asset Management Trust (see advisory)
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 38 2,841 7,376.32 0 11
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 27,100 25,000 -7.75 85 97 14.12
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 32 28 -12.50 0 0
2018-02-12 13F-HR CITIGROUP INC 443 443 0.00 1 2 100.00
2017-11-09 13F-HR INVESTMENT CENTERS OF AMERICA INC 25,050 0 -100.00 15 0 -100.00
2018-02-16 13F-HR/A-1 Commonwealth Equity Services, Inc 425,254 57,919 -86.38 259 182 -29.73
2018-02-14 13F-HR STIFEL FINANCIAL CORP 204,305 195,102 -4.50 640 761 18.91
2018-02-14 13F-HR DEUTSCHE BANK AG\ 8,397 13 -99.85 26 0 -100.00
2018-02-12 13F-HR Bandera Partners LLC 555,000 613,037 10.46 1,743 2,379 36.49
2018-02-14 13F-HR STATE STREET CORP 14,517 23,046 58.75 45 89 97.78
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 1,992 0 -100.00 6 0 -100.00
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 68,542 68,542 0.00 215 266 23.72
2018-02-09 13F-HR Monashee Investment Management LLC 64
2017-11-14 13F-HR/A-1 PERCEPTIVE ADVISORS LLC 24,332 0 -100.00 15 0 -100.00
2018-02-14 13F-HR AQR CAPITAL MANAGEMENT LLC 27,286 27,286 0.00 86 106 23.26
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-02-13 13F-HR Axa 81,700 83,700 2.45 257 325 26.46
2018-02-14 13F-HR VANGUARD GROUP INC 1,518,110 1,442,656 -4.97 4,767 5,598 17.43
2017-11-09 13F-HR FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC 10,000 0 -100.00 6 0 -100.00
2018-02-14 13F-HR Fondren Management LP 205,000 0 -100.00 644 0 -100.00
2018-02-13 13F-HR JP Morgan Chase & Co 72,069 35,829 -50.29 224 139 -37.95
2018-02-14 13F-HR PDT Partners, LLC 82,800 66,900 -19.20 260 260 0.00
2017-10-17 13F-HR Creative Planning 18,200 0 -100.00 11 0 -100.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC 10,700 16,488 54.09 33 63 90.91
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 14,700 42,400 188.44 46 165 258.70
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 0 32,198 0 125
2017-11-13 13F-HR Spark Investment Management LLC 128,600 0 -100.00 78 0 -100.00
2018-02-09 13F-HR BlackRock Inc. 761,302 762,010 0.09 2,391 2,956 23.63
2018-02-20 SC 13D/A STAFFORD JOHN S III 2,977,260 4,177,260 40.31
2017-11-09 13F-HR Burt Wealth Advisors 2,000 0 -100.00 1 0 -100.00
2018-04-03 13F-HR/A-1 LEVEL FOUR ADVISORY SERVICES, LLC 57,700 0 -100.00 37 0 -100.00
2018-01-19 13F-HR Financial Management Professionals, Inc. 32 32 0.00 0 0
2018-02-13 13F-HR OXFORD ASSET MANAGEMENT 73,517 75,377 2.53 231 300 29.87
2018-02-02 13F-HR Alambic Investment Management, L.P. 14,500 0 -100.00 46 0 -100.00
2018-02-14 13F-HR UBS Group AG 2,877 2,877 0.00 9 11 22.22
2018-02-13 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 69,820 0 -100.00 219 0 -100.00
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,123 1,748 55.65 4 7 75.00
2018-02-12 13F-HR Commonwealth Equity Services, Llc. 54,319 211
2017-10-26 13F-HR Raymond James Financial Services Advisors, Inc. 36,400 0 -100.00 22 0 -100.00
2018-02-13 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 52,189 0 -100.00 164 0 -100.00
2017-11-13 13F-HR SYNOVUS FINANCIAL CORP 14,040 0 -100.00 9 0 -100.00
2017-11-14 13F-HR MILLENNIUM MANAGEMENT LLC 28,901 0 -100.00 18 0 -100.00
2017-11-02 13F-HR Sterling Global Strategies LLC 20,000 0 -100.00 12 0 -100.00
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 0 12,100 0 47
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2017-11-15 13F-HR/A-1 BRANDES INVESTMENT PARTNERS, LP 89,100 0 -100.00 54 0 -100.00
2018-02-02 13F-HR Ballentine Partners, LLC 25,001 18,500 -26.00 79 72 -8.86
2018-02-13 13F-HR Renaissance Technologies LLC 547,190 549,106 0.35 1,718 2,131 24.04
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 7,800 7,800 0.00 24 30 25.00
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 9,375 22,961 144.92 29 89 206.90
2017-11-01 13F-HR ROCKLAND TRUST CO 15,000 0 -100.00 9 0 -100.00
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 225,676 225,676 0.00 709 875 23.41
2017-11-09 13F-HR CITADEL ADVISORS LLC Put 12,300 0 -100.00 7 0 -100.00
2018-02-14 13F-HR NORTHERN TRUST CORP 77,870 72,144 -7.35 244 280 14.75
2018-02-14 13F-HR WOLVERINE TRADING, LLC Put 12,100 0 -100.00 38 0 -100.00
2018-02-14 13F-HR Weiss Asset Management LP 13,683 53
2018-04-17 13F-HR Monument Capital Management 16 0 -100.00 0 0
2018-02-09 13F-HR Bank of New York Mellon Corp 27,578 30,492 10.57 87 118 35.63
2017-11-09 13F-HR CITADEL ADVISORS LLC Call 10,700 0 -100.00 7 0 -100.00
2018-02-14 13F-HR Advisor Group, Inc. 2,718 3,719 36.83 8 14 75.00
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 22,488 0 -100.00 88 0 -100.00
2018-02-01 13F-HR ALGERT GLOBAL LLC 120,521 21,042 -82.54 378 82 -78.31
2018-02-14 13F-HR BlueCrest Capital Management Ltd 0 30,643 0 119
2018-02-08 13F-HR SEI INVESTMENTS CO 0 15 0 0
2018-02-21 13F-HR Hanson McClain, Inc. 686 686 0.00 2 3 50.00
2018-02-09 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 143 143 0.00 0 1
2018-04-12 13F-HR Advocacy Wealth Management Services, LLC 1 0 -100.00 0 0
2018-02-14 13F-HR ROYAL BANK OF CANADA 886 1,316 48.53 3 5 66.67

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( PPHM / Peregrine Pharmaceuticals, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 713661304